Published in

Wiley, Diagnostic Cytopathology, 1(52), p. 3-9, 2023

DOI: 10.1002/dc.25226

Links

Tools

Export citation

Search in Google Scholar

Immunoreactivity of TTF‐1, GATA‐3, CEA, and p16/Ki67 cocktail in Cellprep®‐processed control samples: Comparison of long‐term storage in vials and slides

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractIntroductionCellprep® (CP) is a novel liquid‐based cytology (LBC) system. This study aimed to assess the immunoreactivity of control samples stored long‐term under two storage conditions using CP.MethodsThe immunoreactivity in control samples was evaluated under two sample storage conditions: CP vial storage at room temperature (RT: 20–25°C) and CP slide storage in a refrigerator (2–6°C). Clinical samples as controls (total: positive/negative) were immunostained using thyroid transcription factor‐1 (TTF‐1) (20: 14/6), GATA binding protein 3 (GATA‐3) (13: 10/3), carcinoembryonic antigen (CEA) (23: 15/8), and the p16/Ki67 cocktail (20: 12/8) markers. The first immunocytochemistry (ICC) was performed within 1 month using CP vials stored at RT. Samples stored in CP vials and on CP slides were used for the second (within 3–6 months) and third (within 6–11 months) ICCs. Compared with the first ICC, the concordance of immunoreactivity for the second and third ICCs was evaluated using the weighted kappa coefficient.ResultsFor TTF‐1, CEA, and the p16/Ki67 cocktail markers, ICC controls had stable immunoreactivity for a minimum of 6 months when samples were stored in CP vials (kappa coefficients >0.8), whereas for GATA‐3, they were for 3 months. On CP slides, only for the p16/Ki67 cocktail, ICC controls had stable immunoreactivity for at least 3 months (kappa coefficient >0.8).ConclusionClinical samples as ICC controls revealed consistently more stable immunoreactivity in CP vials than on CP slides for TTF‐1, GATA‐3, CEA, and the p16/Ki67 cocktail markers.